Beneficial Effect of a Selective Adenosine A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease

about

The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer's Disease

P2860

Q57896320-A55E76F9-117D-4065-9AC1-C7C272A31332

P2860

Beneficial Effect of a Selective Adenosine A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease

Item

http://www.wikidata.org/entity/Q57896338

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Beneficial Effect of a Selecti ...... e Model of Alzheimer's Disease

@en

Beneficial Effect of a Selecti ...... e Model of Alzheimer's Disease

@nl

type

Item

label

Beneficial Effect of a Selecti ...... e Model of Alzheimer's Disease

@en

Beneficial Effect of a Selecti ...... e Model of Alzheimer's Disease

@nl

prefLabel

Beneficial Effect of a Selecti ...... e Model of Alzheimer's Disease

@en

Beneficial Effect of a Selecti ...... e Model of Alzheimer's Disease

@nl

P1476

Beneficial Effect of a Selecti ...... e Model of Alzheimer's Disease

@en

P2093

Annett Halle

http://www.w3.org/2001/XMLSchema#string

Christa E Müller

http://www.w3.org/2001/XMLSchema#string

Emilie Faivre

http://www.w3.org/2001/XMLSchema#string

Enas Malik

http://www.w3.org/2001/XMLSchema#string

Joana E Coelho

http://www.w3.org/2001/XMLSchema#string

Katja Zornbach

http://www.w3.org/2001/XMLSchema#string

Kevin Carvalho

http://www.w3.org/2001/XMLSchema#string

Lucrezia Cellai

http://www.w3.org/2001/XMLSchema#string

Marion Schneider

http://www.w3.org/2001/XMLSchema#string

Michael Heneka

http://www.w3.org/2001/XMLSchema#string

P2860

Amyloid plaque core protein in Alzheimer disease and Down syndrome

Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity

Optogenetic activation of intracellular adenosine A2A receptor signaling in the hippocampus is sufficient to trigger CREB phosphorylation and impair memory

Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress.

Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology

Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A2A receptors.

Neuroinflammation in Alzheimer's disease

Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A(2A)-selective adenosine receptor antagonists

An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity

Munc18-1 is a dynamically regulated PKC target during short-term enhancement of transmitter release

P304

235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNMOL.2018.00235

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30050407

http://www.w3.org/2001/XMLSchema#string

P921

molecular biology

P932

6052540

http://www.w3.org/2001/XMLSchema#string

Beneficial Effect of a Selective Adenosine A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease

about

P2860

P2860

Beneficial Effect of a Selective Adenosine A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932